New England Biolabs® and seqWell Announce Strategic Partnership and Commercial Launch of High-Performance TnX® Transposase (Unloaded)

PartnershipTnX Transposase (Unloaded)Positive

AI Analysis

Summary

New England Biolabs and seqWell announced a strategic partnership and commercial launch of TnX Transposase for NGS library preparation. The collaboration combines seqWell's TnX-based solutions with NEB's enzyme development and manufacturing expertise.

Importance:5/10

Sentiment:

0.60

partnershipcollaborationNGSenzyme developmentcommercial launch

Related Companies

$GBCMD

Read the original article

Published by PR Newswire Biotech on October 15, 2026 7:00 PM

Read Original